MANULIFE FINANCIAL CORP (MFC): Financial results for Q3 2026
MANULIFE FINANCIAL CORP (MFC) furnished an SEC Form 6-K — earnings release. 1 Manulife Reports Third Quarter 2026 Results TSX/NYSE/PSE: MFC SEHK: 945 C$ unless otherwise stated TORONTO, ON – November 4, 2026 – Manulife Financial Corporation (“Manulife” or the “Company”) reported its third quarter results for the period ended September 30, 2026 , deliveri
How this was made
The 30-second read
Why it matters
The earnings release introduces new financial metrics that can influence analyst forecasts and investor positioning in the insurance sector.
Market read
Manulife's earnings are a primary data point for the insurance and wealth management sectors, affecting both Canadian and U.S. listed insurers.
What to watch
The $1.3B shareholder return and AI‑enabled efficiency gains may offset earnings weakness over the longer term.
Manulife Reports Third Quarter 2026 Results
Record core earnings of $2.1 billion, core EPS of $1.24 and Core ROE of 17.8% were supported by Asia and U.S. growth, while reported net income attributed to shareholders declined to $1.4 billion amid market-experience losses and a Vietnam-related charge.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net income attributed to shareholders, 3Q26GAAP | $1.42B | – | (22)% |
| Core earnings, 3Q26non-GAAP | $2.13B | – | 4% |
| EPS, 3Q26GAAP | $0.82 | – | (21)% |
| Core EPS, 3Q26non-GAAP | $1.24 | – | 6% |
| ROE, 3Q26other | 11.8% | – | (4.2) pps |
| Core ROE, 3Q26non-GAAP | 17.8% | – | (0.3) pps |
| Book value per common share, 3Q26other | $28.06 | – | 8% |
| Adjusted book value per common share, 3Q26non-GAAP | $41.78 | – | 9% |
| Financial leverage ratio, 3Q26non-GAAP | 23.0% | – | 0.3 pps |
| APE sales, 3Q26other | $2.63B | – | (0)% |
| New business CSM, 3Q26non-GAAP | $957M | – | (2)% |
| NBV, 3Q26other | $907M | – | (1)% |
| Global WAM net flows, 3Q26other | −$3.6B | – | 43% |
| Global WAM average AUMA, 3Q26other | $1.20T | – | 11% |
| Global WAM core revenue, 3Q26non-GAAP | $2.29B | – | – |
| Global WAM core EBITDA, 3Q26non-GAAP | $677M | – | – |
| Global WAM core EBITDA margin, 3Q26non-GAAP | 29.6% | – | -130 bps |
| Core expenses, 3Q26non-GAAP | $1.83B | – | – |
| CSM, September 30, 2026other | $29.07B | – | – |
| CSM, net of NCI, September 30, 2026other | $27.32B | – | – |
| Post-tax CSM net of NCI, September 30, 2026non-GAAP | $22.70B | – | – |
| Organic CSM movement, 2026 year-to-dateother | $1.62B | – | 9% annualized growth in our CSM net of NCI balance |
| Inorganic CSM movement, 2026 year-to-dateother | $727M | – | – |
| LICAT ratio, September 30, 2026other | 136% | – | – |
| Common shareholders’ equity, September 30, 2026other | $46.41B | – | – |
| Adjusted book value, September 30, 2026non-GAAP | $69.11B | – | – |
| Net income attributed to shareholders, 2026 year-to-dateGAAP | $4.68B | – | 15% |
| Core earnings, 2026 year-to-datenon-GAAP | $5.88B | – | 8% |
| EPS, 2026 year-to-dateGAAP | $2.67 | – | 18% |
| Core EPS, 2026 year-to-datenon-GAAP | $3.39 | – | 11% |
| Net income attributed to shareholders, 3Q26 market experience gains (losses)other | −$388M | – | – |
| Net income attributed to shareholders, 3Q26 updates to actuarial methods and assumptions that flow directly through incomeother | −$175M | – | – |
| Net income attributed to shareholders, 3Q26 amortization of acquisition-related intangible assetsother | −$18M | – | – |
| Net income attributed to shareholders, 3Q26 reinsurance transactions, tax-related items and otherother | −$120M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Global WAMHigher net fee income from favourable market impacts over the past 12 months and contributions from the Manulife | Comvest business were more than offset by the impact of the eMPF transition in Hong Kong, higher workforce-related expenses and investment in business growth, favourable tax true-ups in 3Q25, and lower performance fees. | $2.29B | – | – |
Capital returns
- Returned $1.3 billion to shareholders during the quarter.
What drove it
- Asia core earnings increased 17%, reflecting continued business growth, the net positive impact of 3Q26 updates to actuarial methods and assumptions, improved impact of new business and improved claims experience, partially offset by increased ECL provisions.
- Canada core earnings increased 3%, reflecting more favourable claims experience in Individual Insurance, higher Manulife Bank earnings and higher investment spreads.
- U.S. core earnings increased 5%, reflecting favourable life insurance claims experience, business growth and favourable tax items.
- Global WAM institutional asset management net inflows were $1.4 billion, compared with net outflows of $0.7 billion in 3Q25.
- The annual actuarial-methods-and-assumptions review resulted in a net favourable impact of a $128 million decrease in pre-tax fulfilment cash flows.
- In Global WAM, Manulife | Comvest raised US$5.4 billion of capital through the close of Comvest Credit Partners VII.
Concerns
- Net income attributed to shareholders was $0.4 billion lower compared with 3Q25, driven by a larger net charge on market experience and a net charge from Vietnam operations.
- Market experience losses were $(388) million in 3Q26, reflecting lower than expected returns on alternative long-duration assets, lower than expected returns on public equities, and losses from derivatives and hedge accounting ineffectiveness.
- Global WAM core earnings decreased 5% and core EBITDA margin declined -130 bps to 29.6%.
- Global WAM retirement net outflows were $4.9 billion, compared with net outflows of $1.6 billion in 3Q25.
- U.S. new business CSM declined 20% and NBV declined 13% as changes in product mix affected results.
- Corporate and Other core earnings decreased by $55 million, driven by the non-recurrence of a 3Q25 withholding tax adjustment and lower earnings on surplus assets.
What to watch
- Whether Asia sales growth in Hong Kong and Japan continues to offset lower sales in the Chinese Mainland.
- The development of Global WAM retirement plan redemptions in the U.S., net member withdrawals, and Canadian new plan sales.
- The effect of the Hong Kong eMPF transition, workforce-related expenses, growth investment and performance fees on Global WAM earnings and margin.
- Expected credit loss provisions, alternative long-duration asset performance, public-equity returns, derivatives and hedge accounting ineffectiveness.
- The impact of new business product mix on U.S. new business CSM and NBV.
Balance sheet and cash flow
- LICAT ratio of 136%.
- Financial leverage ratio of 23.0%.
- Common shareholders’ equity of $46,412 million as at September 30, 2026.
- Adjusted book value of $69,113 million as at September 30, 2026.
- CSM was $27,318 million as at September 30, 2026.
- Post-tax CSM net of NCI was $22,701 million as at September 30, 2026.
Analysis
Manulife reported record core earnings of $2,125 million in 3Q26, up 4% on a CER basis from $2,035 million in 3Q25. Core EPS rose 6% to $1.24, while Core ROE was 17.8%, compared with 18.1% in the prior-year quarter. Reported net income attributed to shareholders fell 22% to $1,424 million and EPS declined 21% to $0.82. The divergence reflected $(388) million of market-experience losses and $(175) million from actuarial-methods-and-assumptions updates that flowed directly through income, alongside $(120) million of reinsurance transactions, tax-related items and other exclusions.
Asia was the principal earnings contributor. Asia core earnings were US$635 million, up 17%, supported by business growth, the net positive actuarial-review impact, improved new-business impact and improved claims experience. Canada core earnings increased 3% to $440 million and U.S. core earnings increased 5% to US$254 million. Asia APE sales were US$1,455 million, new business CSM was US$518 million and NBV was US$491 million, each broadly in line with 3Q25. Canada delivered 3% APE sales growth and 5% new-business-CSM growth, while U.S. product mix drove declines of 20% in new business CSM and 13% in NBV.
Global WAM produced $2,288 million of core revenue and $677 million of core EBITDA, but core earnings declined 5% to $503 million and core EBITDA margin fell -130 bps to 29.6%. Higher net fee income and Manulife | Comvest contributions were outweighed by the eMPF transition in Hong Kong, workforce expense, growth investment, favourable prior-year tax true-ups and lower performance fees. Net outflows improved to $(3.6) billion from $(6.2) billion, helped by retail flows that were neutral and $1.4 billion of institutional asset-management net inflows. Retirement net outflows nonetheless widened to $4.9 billion from $1.6 billion.
The balance sheet remained a stated strength, with a 136% LICAT ratio and a 23.0% financial leverage ratio. CSM net of NCI reached $27,318 million, up $2,349 million compared with December 31, 2025, while post-tax CSM net of NCI was $22,701 million. Organic CSM movement contributed $1,622 million, representing 9% annualized growth in the CSM net of NCI balance, and inorganic movement added $727 million. The company returned $1.3 billion to shareholders during the quarter. No forward financial guidance was provided in the filing.
Management, verbatim
We delivered strong third quarter results, achieving record core EPS and 17.8% core ROE, driven by double- digit core earnings growth in Asia and meaningful contributions from our North American insurance businesses. These results reflect the disciplined execution of the strategy we launched a year ago and our ability to deliver sustained growth in an uncertain environment.
Phil Witherington, Manulife President & Chief Executive Officer
We remained disciplined in our capital deployment during the quarter, returning $1.3 billion to shareholders while maintaining a strong balance sheet, with a LICAT ratio of 136% and a financial leverage ratio below our medium-term target. In addition, we completed our annual review of actuarial methods and assumptions, resulting in a net favourable impact and reinforcing the robustness of our reserves.
Colin Simpson, Manulife Chief Financial Officer
Not in the filing
stated, not guessed- Total company revenue was not reported.
- Gross margin was not reported.
- Operating income was not reported.
- Operating cash flow was not reported.
- Free cash flow was not reported.
- Cash and debt balances were not reported.
- Dividend amount and share-repurchase amount were not separately reported.
- Forward financial guidance was not provided.
- Prior-release outlook was not provided.
- Segment revenue was not reported for Asia, Canada or U.S.; the filing reports segment earnings and sales metrics rather than revenue for those businesses.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Manulife, a major Canadian insurer and wealth manager, filed its Q3 2026 results via SEC Form 6‑K, providing detailed segment performance and strategic updates.
Ticker impact
Manulife Financial Corp released its Q3 2026 earnings, reporting record core earnings of $2.1B but net income down 22% YoY.
likely slight pressure as investors digest lower net income despite earnings growth
The decline in net income and lower EPS outweigh the modest core earnings increase, prompting a cautious market reaction.
Market effects
Insurance and wealth management sector may see re‑rating as Manulife's net income decline signals pressure on profitability.
Canadian market could experience modest pullback given Manulife's weight in the TSX.
Limited global impact; primarily affects North American insurers and asset managers.
Counterpoint
Core earnings growth and strong AI initiatives could support upside if market focuses on long‑term growth rather than short‑term income dip.
Key entities
- companyManulife Financial Corp
Issuer of the earnings release.
- executivePhil Witherington
President & CEO who commented on the results.
